Carrie Brownstein - 14 Jul 2025 Form 4 Insider Report for Shattuck Labs, Inc. (STTK)

Reporting relationship: Director
Issuer ticker: STTK
Reported as of: 14 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jul 2025, 16:13:31 UTC
Prior SEC filing: 21 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Andrew R. Neill, Attorney-in-Fact for Carrie Brownstein

Key filing fact

Carrie Brownstein filed Form 4 for Shattuck Labs, Inc. (STTK) on 16 Jul 2025.

Key facts

This page summarizes Carrie Brownstein's Form 4 filing for Shattuck Labs, Inc. (STTK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Jul 2025, 16:13.

Change

Previous filing in this sequence was filed on 21 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001894232 Primary reporting owner

Brownstein Carrie

Relationship: Director
Address: C/O SHATTUCK LABS, INC., 500 W. 5TH STREET, SUITE 1200, AUSTIN
Signature: /s/ Andrew R. Neill, Attorney-in-Fact for Carrie Brownstein
Signature date: 16 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STTK transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +33,150
Change %
Price: $0.000000
Shares after: 33,150
Date: 14 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 33,150
Exercise price: $0.8200
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option represents the right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.